$276.0 Million
Design Therapeutics
Initial Public Offering
Active Bookrunner
$93.7 Million
Reneo Pharmaceuticals
Initial Public Offering
Active Bookrunner
$253.9 Million
Talis Biomedical
Initial Public Offering
Active Bookrunner
$152.5 Million
Sensei Biotherapeutics, Inc.
Initial Public Offering
Active Bookrunner
$151.3 Million
Akoya Biosciences, Inc.
Initial Public Offering
Active Bookrunner
$219.9 Million
Connect Biopharma
Initial Public Offering
Active Bookrunner
$124.9 Million
Rain Therapeutics
Initial Public Offering
Active Bookrunner
$175.0 Million
Achilles Therapeutics
Initial Public Offering
Active Bookrunner
$240.0 Million
Gracell Bio
Initial Public Offering
Active Bookrunner
$287.5 Million
Kronos Bio
Initial Public Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.